Robert McCormack, PhD | Authors

Articles

An Analysis of the SWOG S0500 Study

March 04, 2014

Robert McCormack, PhD, head, Technology Innovation, Janssen Diagnostics, LLC, discusses the SWOG S0500 study, which evaluated different treatments in patients with metastatic breast cancer who had elevated circulating tumor cell (CTC) levels.